Clinical Trials
10
Active:7
Completed:3
Trial Phases
2 Phases
Phase 1:7
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 1
7 (77.8%)Phase 2
2 (22.2%)A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis
Phase 1
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: ZPL-5212372 1% w/w Ointment BIDDrug: Placebo Ointment BID
- First Posted Date
- 2016-06-10
- Last Posted Date
- 2019-04-05
- Lead Sponsor
- Ziarco Pharma Ltd
- Target Recruit Count
- 53
- Registration Number
- NCT02795832
- Locations
- 🇬🇧
MAC, Manchester, United Kingdom
A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis
- First Posted Date
- 2015-12-01
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Ziarco Pharma Ltd
- Target Recruit Count
- 129
- Registration Number
- NCT02618616
- Locations
- 🇧🇪
Belgium Study Centre, Liège, Belgium
🇩🇪German Study Centre, Münster, Germany
🇵🇱Polish Study Centre, Łódź, Poland
A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis
- First Posted Date
- 2015-04-23
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- Ziarco Pharma Ltd
- Target Recruit Count
- 98
- Registration Number
- NCT02424253
- Locations
- 🇧🇪
Belgium Study Site, Liege, Belgium
🇩🇪German Study Site, Munster, Germany
🇵🇱Polish Study Site, Tarnow, Poland
News
No news found